PHARMASGP HOLDING SE O.N.
PHARMASGP HOLDING SE O.N./ DE000A2P4LJ5 /
PSG
|
2024-11-15 2:41:14 PM
|
Chg.
+0.60
|
Volume |
Bid5:36:06 PM |
Ask5:36:06 PM |
Market Capitalization |
Dividend Y. |
P/E Ratio |
|
26.40EUR
|
+2.33%
|
211
Turnover: 5,447.40 |
23.60Bid Size: 50 |
25.80Ask Size: 50 |
304.61 mill.EUR |
5.35% |
18.54 |
Business description
PharmaSGP is a pure-play consumer health company with a broad portfolio of leading chemical-free non-prescription pharmaceuticals sold over the counter (“OTC”) and other healthcare products. PharmaSGP’s products are sold exclusively through pharmacies. Its products are based on natural active pharmaceutical ingredients with documented efficacy and fewer known side effects than most chemical-based pharmaceuticals. The Company’s core brands cover chronic indications, including pain and other age-related ailments.
Management board & Supervisory board
| CEO |
| Natalie Weigand |
| Management board |
| Michael Rudolf, Peter Gerckens |
| Supervisory board |
| Dr. Clemens Fischer, Madlena Hohlefelder, Dr. Axel Rebien |
Company data
| Name: |
PharmaSGP Holding SE |
| Address: |
Lochhamer Schlag 21,D-82166 Gräfelfing |
| Phone: |
+49-611-2058-5528 |
| Fax: |
+49-611-2058-5566 |
| E-mail: |
info@pharmasgp.com
|
| Internet: |
https://pharmasgp.com/ |
| Industry: |
Healthcare |
| Sector: |
Pharmaceutical Industry |
| Sub sector: |
Pharmaceuticals |
| End of financial year: |
12-31 |
| Free Float: |
- |
| IPO date: |
2020-06-19 |
Investor relations
| Name: |
Claudius Krause |
| IR phone: |
+49-611-2058-5535 |
| IR Fax: |
- |
| IR e-mail: |
ir@pharmasgp.com
|
Company calendar
|
CW 48 | 2024-11-28
Interim Report 3rd Quarter/9 Months
|
